Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles

Eduardo Fuentes, Basit Yameen, Soung Jae Bong, Carolina Salvador-Morales, Ivan Palomo, Cristian Vilos

Resultado de la investigación: Contribución a la publicaciónArticle

  • 1 Citas

Resumen

PEGylated nanoparticles have been extensively investigated in different platforms for drug delivery. However, the physiological effects related to platelet activation, and the potential procoagulant activity which could lead to thrombosis and further cardiovascular diseases have not been widely examined. In this work, we studied the effect of differentially charged PEGylated lipid-polymer nanoparticles in the human platelet aggregation and activation by light transmission aggregometry and flow cytometry. PEGylated nanoparticles inhibited the platelet aggregation with a dose dependency (350, 700, and 1400 μg/mL) in both ADP- and collagen-induced platelet aggregation, and P-selectin expression. Charged nanoparticles (anionic and cationic) presented higher inhibitions of the platelet aggregation compared to neutral nanoparticles, and particularly the cationic particles generated a slightly higher effect. The obtained results demonstrated the safety of the differentially charged PEGylated lipid-polymer nanoparticles, and their ability to inhibit the aggregation and activation of human platelets stimulated by two classic platelet activators.

Idioma originalEnglish
Páginas (desde - hasta)1089-1094
Número de páginas6
PublicaciónNanomedicine: Nanotechnology, Biology, and Medicine
Volumen13
Número de edición3
Identificadores de objetos digitales
EstadoPublished - 1 abr 2017

Huella dactilar

Nanoparticles
Polymers
Lipids
Platelets
Agglomeration
Platelet Aggregation
Platelet Activation
Chemical activation
P-Selectin
Adenosine Diphosphate
Flow Cytometry
Thrombosis
Cardiovascular Diseases
Collagen
Blood Platelets
Safety
Administrative data processing
Flow cytometry
Light transmission
Drug delivery

Keywords

    ASJC Scopus subject areas

    • Medicine (miscellaneous)
    • Bioengineering
    • Biomedical Engineering
    • Molecular Medicine
    • Materials Science(all)
    • Pharmaceutical Science

    Citar esto

    Fuentes, Eduardo; Yameen, Basit; Bong, Soung Jae; Salvador-Morales, Carolina; Palomo, Ivan; Vilos, Cristian / Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles.

    En: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, N.º 3, 01.04.2017, p. 1089-1094.

    Resultado de la investigación: Contribución a la publicaciónArticle

    @article{2f0549f6e7304779a6bb65acbf29a123,
    title = "Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles",
    abstract = "PEGylated nanoparticles have been extensively investigated in different platforms for drug delivery. However, the physiological effects related to platelet activation, and the potential procoagulant activity which could lead to thrombosis and further cardiovascular diseases have not been widely examined. In this work, we studied the effect of differentially charged PEGylated lipid-polymer nanoparticles in the human platelet aggregation and activation by light transmission aggregometry and flow cytometry. PEGylated nanoparticles inhibited the platelet aggregation with a dose dependency (350, 700, and 1400 μg/mL) in both ADP- and collagen-induced platelet aggregation, and P-selectin expression. Charged nanoparticles (anionic and cationic) presented higher inhibitions of the platelet aggregation compared to neutral nanoparticles, and particularly the cationic particles generated a slightly higher effect. The obtained results demonstrated the safety of the differentially charged PEGylated lipid-polymer nanoparticles, and their ability to inhibit the aggregation and activation of human platelets stimulated by two classic platelet activators.",
    keywords = "Charged nanoparticle, Lipid polymer, PEGylated nanoparticle, Platelet",
    author = "Eduardo Fuentes and Basit Yameen and Bong, {Soung Jae} and Carolina Salvador-Morales and Ivan Palomo and Cristian Vilos",
    year = "2017",
    month = "4",
    doi = "10.1016/j.nano.2016.10.010",
    volume = "13",
    pages = "1089--1094",
    journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
    issn = "1549-9634",
    publisher = "Elsevier Inc.",
    number = "3",

    }

    Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles. / Fuentes, Eduardo; Yameen, Basit; Bong, Soung Jae; Salvador-Morales, Carolina; Palomo, Ivan; Vilos, Cristian.

    En: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 13, N.º 3, 01.04.2017, p. 1089-1094.

    Resultado de la investigación: Contribución a la publicaciónArticle

    TY - JOUR

    T1 - Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles

    AU - Fuentes,Eduardo

    AU - Yameen,Basit

    AU - Bong,Soung Jae

    AU - Salvador-Morales,Carolina

    AU - Palomo,Ivan

    AU - Vilos,Cristian

    PY - 2017/4/1

    Y1 - 2017/4/1

    N2 - PEGylated nanoparticles have been extensively investigated in different platforms for drug delivery. However, the physiological effects related to platelet activation, and the potential procoagulant activity which could lead to thrombosis and further cardiovascular diseases have not been widely examined. In this work, we studied the effect of differentially charged PEGylated lipid-polymer nanoparticles in the human platelet aggregation and activation by light transmission aggregometry and flow cytometry. PEGylated nanoparticles inhibited the platelet aggregation with a dose dependency (350, 700, and 1400 μg/mL) in both ADP- and collagen-induced platelet aggregation, and P-selectin expression. Charged nanoparticles (anionic and cationic) presented higher inhibitions of the platelet aggregation compared to neutral nanoparticles, and particularly the cationic particles generated a slightly higher effect. The obtained results demonstrated the safety of the differentially charged PEGylated lipid-polymer nanoparticles, and their ability to inhibit the aggregation and activation of human platelets stimulated by two classic platelet activators.

    AB - PEGylated nanoparticles have been extensively investigated in different platforms for drug delivery. However, the physiological effects related to platelet activation, and the potential procoagulant activity which could lead to thrombosis and further cardiovascular diseases have not been widely examined. In this work, we studied the effect of differentially charged PEGylated lipid-polymer nanoparticles in the human platelet aggregation and activation by light transmission aggregometry and flow cytometry. PEGylated nanoparticles inhibited the platelet aggregation with a dose dependency (350, 700, and 1400 μg/mL) in both ADP- and collagen-induced platelet aggregation, and P-selectin expression. Charged nanoparticles (anionic and cationic) presented higher inhibitions of the platelet aggregation compared to neutral nanoparticles, and particularly the cationic particles generated a slightly higher effect. The obtained results demonstrated the safety of the differentially charged PEGylated lipid-polymer nanoparticles, and their ability to inhibit the aggregation and activation of human platelets stimulated by two classic platelet activators.

    KW - Charged nanoparticle

    KW - Lipid polymer

    KW - PEGylated nanoparticle

    KW - Platelet

    UR - http://www.scopus.com/inward/record.url?scp=85013459668&partnerID=8YFLogxK

    U2 - 10.1016/j.nano.2016.10.010

    DO - 10.1016/j.nano.2016.10.010

    M3 - Article

    VL - 13

    SP - 1089

    EP - 1094

    JO - Nanomedicine: Nanotechnology, Biology, and Medicine

    T2 - Nanomedicine: Nanotechnology, Biology, and Medicine

    JF - Nanomedicine: Nanotechnology, Biology, and Medicine

    SN - 1549-9634

    IS - 3

    ER -

    Fuentes E, Yameen B, Bong SJ, Salvador-Morales C, Palomo I, Vilos C. Antiplatelet effect of differentially charged PEGylated lipid-polymer nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine. 2017 abr 1;13(3):1089-1094. Disponible desde, DOI: 10.1016/j.nano.2016.10.010